These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24408865)

  • 1. Temporal trends of copper-bearing intrauterine device discontinuation: a population-based birth-cohort study of contraceptive use among rural married women in China.
    Zhou J; Tan X; Song X; Zhang K; Fang J; Peng L; Qi W; Nie Z; Li M; Deng R; Yan C
    Asia Pac J Public Health; 2015 Mar; 27(2):NP2433-42. PubMed ID: 24408865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China.
    Xu JX; Rivera R; Dunson TR; Zhuang LQ; Yang XL; Ma GT; Chi IC
    Contraception; 1996 Jul; 54(1):33-8. PubMed ID: 8804806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the personal reasons for discontinuing IUD use.
    Petta CA; Amatya R; Farr G; Chi I
    Contraception; 1994 Oct; 50(4):339-47. PubMed ID: 7813222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD.
    Rivera R; Chen-Mok M; McMullen S
    Contraception; 1999 Sep; 60(3):155-60. PubMed ID: 10640159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do insertion-related problems affect subsequent IUD performance?
    Chi IC; Waszak CS; Wilkens LR
    Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of copper intrauterine devices when inserted after an expulsion.
    Bahamondes L; Díaz J; Marchi NM; Petta CA; Cristofoletti ML; Gomez G
    Hum Reprod; 1995 Nov; 10(11):2917-8. PubMed ID: 8747044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-coital intrauterine device insertion - a further evaluation.
    Black TR; Goldstuck ND; Spence A
    Contraception; 1980 Dec; 22(6):653-8. PubMed ID: 7214912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine contraception after medical abortion: factors affecting success of early insertion.
    Pohjoranta E; Suhonen S; Mentula M; Heikinheimo O
    Contraception; 2017 Mar; 95(3):257-262. PubMed ID: 27836586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with the copper 7 intrauterine device in an adolescent population.
    Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
    J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A random control study of indomethacin-containing MYCu intrauterine contraceptive device for 60 months].
    Wang LY; Li SZ; Wu SY; Zhao YH; Wang Y
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):496-9. PubMed ID: 23660315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with discontinuation rates of the copper T380A IUD in a Peruvian public hospital.
    Escudero F; Gonzales GF; Delgadillo L; Villena AE
    Adv Contracept; 1999; 15(4):303-11. PubMed ID: 11145372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A one-year cohort study of complications, continuation, and failure rates of postpartum TCu380A in Tanzania.
    Rwegoshora FJ; Muganyizi PS; Kimario GF; Paul PP; Makins A
    Reprod Health; 2020 Oct; 17(1):150. PubMed ID: 33023611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.